Characterization of doravirine-selected resistance patterns from participants in treatment-naive Phase 3 clinical trials

被引：0
|
作者：
Lai, M. -T. [1 ]
Xu, M. [2 ]
Ngo, W. [3 ]
Feng, M. [3 ]
Hazuda, D. [3 ]
Hanna, G. [4 ]
Kumar, S. [5 ]
Xu, X. [6 ]
Martin, E. [4 ]
Hwang, C. [4 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Merck & Co Inc, Dept Pharmacol, West Point, PA USA
[3] Merck & Co Inc, Dept Antiviral Res, West Point, PA USA
[4] Merck & Co Inc, Dept Clin Res, West Point, PA USA
[5] Merck & Co Inc, Dept Clin Sci & Study Management, West Point, PA USA
[6] Merck & Co Inc, Dept Biostat, West Point, PA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
THPDB0101
引用
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [21] Long-Term Hematologic Response to Oral Eliglustat in Treatment-Naive Patients with Gaucher Disease Type 1: Final Results from a Phase 2 and the Phase 3 Engage Trials
    Lau, Heather
    Lukina, Elena
    Mistry, Pramod
    Wu, Yaoshi
    Gaemers, Sebastiaan J. M.
    Peterschmitt, M. Judith
    BLOOD, 2017, 130
  • [22] Treatment Responses in Antiretroviral Treatment-Naive Premenopausal and Postmenopausal HIV-1-Infected Women: An Analysis from AIDS Clinical Trials Group Studies
    Patterson, Kristine B.
    Cohn, Susan E.
    Uyanik, Jennifer
    Hughes, Michael
    Smurzynski, Marlene
    Eron, Joseph J.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (03) : 473 - 476
  • [23] Beta-cell function in treatment-naive patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials
    Blueher, Matthias
    Malhotra, Ankur
    Bader, Giovanni
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1403 - 1407
  • [24] Analysis of protocol defined virologic failure through week 48 from a phase 2 trial (P011) of islatravir and doravirine in treatment-naive adults with HIV-1 infection
    Orkin, C.
    Molina, J. -M.
    Yazdanpanah, Y.
    Anania, C. Chahlin
    DeJesus, E.
    Eron, J.
    Klopfer, S.
    Grandhi, A.
    Eves, K.
    Rudd, D.
    Robertson, M.
    Sklar, P.
    Hwang, C.
    Hanna, G.
    Correll, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 15 - 16
  • [25] Analysis of protocol-defined virologic failure through 96 weeks from a phase II trial (P011) of islatravir and doravirine in treatment-naive adults with HIV-1
    Orkin, C.
    Molina, J.
    Yazdanpanah, Y.
    Chahin Anania, C.
    DeJesus, E.
    Eron, J.
    Klopfer, S.
    Grandhi, A.
    Xu, J.
    Eves, K.
    Hepler, D.
    Robertson, M.
    Hwang, C.
    Hanna, G.
    Correll, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 51 - 52
  • [26] Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations
    Wong, Alexander
    Goldstein, Deborah
    Mallolas, Josep
    DeJesus, Edwin
    Johnson, Margaret
    Molina, Jean-Michel
    Pozniak, Anton
    Rodgers, Anthony
    Teal, Valerie
    Hepler, Deborah
    Kumar, Sushma
    Sklar, Peter
    Hanna, George J.
    Hwang, Carey
    Badshah, Cyrus
    Teppler, Hedy
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (04) : E47 - E49
  • [27] PREDICTORS OF UTILITY OVER TIME AMONG PATIENTS WITH TREATMENT-NAIVE ADVANCED MELANOMA FROM THE PHASE 3 CHECKMATE 066 TRIAL
    Paly, V
    Colby, C.
    Gilloteau, I
    Exuzides, A.
    Briggs, A.
    VALUE IN HEALTH, 2015, 18 (07) : A474 - A474
  • [28] PREDICTORS OF UTILITY OVER TIME AMONG PATIENTS WITH TREATMENT-NAIVE ADVANCED MELANOMA FROM THE PHASE 3 CHECKMATE 067 TRIAL
    Paly, V
    Colby, C.
    Sabater, J.
    Kotapati, S.
    VALUE IN HEALTH, 2016, 19 (03) : A157 - A157
  • [29] Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-naive Children with Growth Hormone Deficiency: the Phase 3 heiGHt Trial"
    Malozowski, Saul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : E2206 - E2207
  • [30] T cell type abundance and gene expression patterns in the context of clinical progression of treatment-naive CLL/MBL patients from the OxPLoreD study
    Gafencu, Grigore-Aristide
    Appleby, Niamh
    Rich-Griffin, Charlotte
    Dooley, Kyla
    Uhlig, Holm
    Dendrou, Calliope
    Vavoulis, Dimitris
    Schuh, Anna
    LEUKEMIA & LYMPHOMA, 2023, 64 : S36 - S37
12345